Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report

被引:0
|
作者
Ali, Elrazi A. [1 ]
Jain, Monika [1 ]
Pokhrel, Akriti [2 ]
Mooppan, Unni [3 ]
Wang, Jen chin [2 ]
机构
[1] One Brooklyn Hlth, Interfaith Med Ctr, Internal Med Dept, Brooklyn, NY USA
[2] One Brooklyn Hlth, Brookdale Univ Hosp, Med Ctr, Dept Hematol & Med Oncol, Brooklyn, NY 11213 USA
[3] One Brooklyn Hlth, Brookdale Univ Hosp, Med Ctr, Dept Urol, Brooklyn, NY 11212 USA
来源
LEUKEMIA RESEARCH REPORTS | 2024年 / 22卷
关键词
Aplastic anemia; Olaparib; Prostate cancer; Pancytopenia; ACUTE MYELOID-LEUKEMIA;
D O I
10.1016/j.lrr.2024.100473
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Olaparib is (ADP-ribose) polymerase inhibitor (PARPi), which stops the repair of single-stranded DNA breaks. This leads to the death of cancer cells with BRCA1/BRCA2 mutations or homologous recombination deficiency. Since being approved by the FDA in 2023 for treating castrate-resistant prostate cancer (CRPC), there have been some reports of myelodysplastic syndrome (MDS) and acute leukemia linked to PARP inhibitor use for ovarian, breast, pancreatic and breast cancers, there have been no reports of aplastic anemia after receiving PARPi therapy. This case report describes a 75-year-old man with BRCA2-positive metastatic castrate-resistant prostate cancer who developed aplastic anemia after taking olaparib.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Prolonged Remission of Fulminant Castrate-Resistant Prostate Cancer: A Case Report
    Bilen, Mehmet Asim
    General, Rosale
    Tu, Shi-Ming
    CLINICAL GENITOURINARY CANCER, 2011, 9 (02) : 133 - 136
  • [2] Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer
    Sekine, Mana
    Terui, Hitoshi
    Fujimura, Taku
    Asano, Yoshihide
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 434 - 436
  • [3] Ureteral metastasis from locally invasive, castrate-resistant prostate cancer: a case report
    Janatpour, Zachary C.
    Shanmuga, Santosh
    Gandia, Edwin
    Rosner, Inger L.
    UROLOGY CASE REPORTS, 2021, 39
  • [4] Periodontal management of a patient with severe aplastic anemia: a case report
    Agnihotri, Rupali
    Bhat, Khandige Mahalinga
    Bhat, Giliyar Subraya
    Pandurang, Pratibha
    SPECIAL CARE IN DENTISTRY, 2009, 29 (03) : 141 - 144
  • [5] Recurrent ovarian hemorrhage in a patient with aplastic anemia A case report
    Yang, Hua-Di
    Xia, Meng-Ting
    Shao, Yi-Feng
    Ying, Pian
    MEDICINE, 2018, 97 (27)
  • [6] SEVERE APLASTIC-ANEMIA INDUCED BY TICLOPIDINE - REPORT OF A CASE
    SU, CC
    TSENG, CD
    HWANG, JJ
    TIEN, HF
    LEE, YT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1995, 94 (11) : 689 - 691
  • [7] Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer
    Cremante, Malvina
    Puglisi, Silvia
    Gandini, Annalice
    Guadagno, Antonio
    Catalano, Fabio
    Damassi, Alessandra
    Murianni, Veronica
    Obispo, Miguel Angel Llaja
    Banna, Giuseppe Luigi
    Buti, Sebastiano
    Rebuzzi, Sara Elena
    Rescigno, Pasquale
    Fornarini, Giuseppe
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1748 - 1753
  • [8] Case report a case of durvalumab induced aplastic anemia after chemoradiotherapy for NSCLC
    Mori, Kengo
    Nishii, Kazuya
    Kitamura, Wataru
    Urata, Tomohiro
    Baba, Takahiro
    Omori, Hiroki
    Nakanishi, Masamoto
    Tamura, Tomoki
    Kuyama, Shoichi
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 8
  • [9] Nivolumab-induced aplastic anemia: A case report and literature review
    Comito, Rachel R.
    Badu, Lynette A.
    Forcello, Nicholas
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (01) : 221 - 225
  • [10] Olaparib-Induced Cutaneous Vasculitis in a Patient with Ovarian Cancer: A Case Report and Literature Review
    Juliana Cantor-Niño
    Nicolás Duque-Clavijo
    Andrés Felipe Bejarano-Ramirez
    Henry Vargas
    Javier Mauricio Segovia
    Luis Eduardo Pino
    Erick Cantor
    SN Comprehensive Clinical Medicine, 7 (1)